NDC 0832-0044-89 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0044
- Requested NDC
- 0832-0044-89
- Package NDCs from labels
- 0832-0044-09, 0832-0044-10, 0832-0044-89, 0832-0044-01
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Upsher-Smith Laboratories, LLC | Upsher-Smith Laboratories, LLC | 2020-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| calcium phosphate, dibasic, dihydrate | INACTIVE INGREDIENT | O7TSZ97GEP | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals, Inc. | 01139e81-a4fa-4e13-acdf-c75c79a1aa9c | 2026-02-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 1ff04bd2-9926-48a4-9afc-eab0789dba01 | 2026-02-23 | Warnings, Adverse reactions | 864V2Q084H |
| Exforge | AMLODIPINE BESYLATE AND VALSARTAN | Novartis Pharmaceuticals Corporation | d0caec89-96ec-411d-a933-63eda74a6da7 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 043c4742-081d-4bc4-bf27-dad92bb2dfbc | 2026-02-12 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | REMEDYREPACK INC. | ea774c36-e970-4d9c-9487-6cc57741fec5 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 4a2bba2d-9b7a-f43a-e063-6294a90af80e | 2026-02-06 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | 5813e6b6-f524-4fba-99ba-9f4e365bf523 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | c56a384c-b250-4a43-99ce-ddd88376c817 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 3b13554a-0f63-4238-8f55-a1400c847c9f | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49e5eeaa-7506-f42a-e063-6294a90a2864 | 2026-02-03 | Warnings | O7TSZ97GEP |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f94296-3e74-1828-e063-6394a90a97d5 | 2026-02-03 | Warnings | O7TSZ97GEP |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f942e6-ceef-5505-e063-6394a90a113f | 2026-02-03 | Warnings | O7TSZ97GEP |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | REMEDYREPACK INC. | cb87f119-1598-405f-b627-eec749c8d42c | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 41496b0d-f1ca-4e9d-e063-6394a90aec1d | 2026-01-29 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 350c7317-a92d-4bcb-973f-19d6de87ed83 | 2026-01-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 49104797-8202-1376-e063-6294a90adb38 | 2026-01-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 3ab4ad3d-7795-058a-e063-6294a90abc86 | 2026-01-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 743ae641-14e1-456b-80e6-c6f7d621e969 | 2026-01-16 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 6e038d92-09f3-4517-947e-146d007114b8 | 2026-01-14 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AvKARE | 1b30c3fe-5c84-0d42-e063-6394a90a81d8 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.